Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Neurology

Why Do I Need ICU Monitoring for Breathing With AIDP?

At a Glance

AIDP can spread from leg weakness to the muscles used for breathing, swallowing, and coughing. ICU monitoring repeats breathing strength tests and checks heart rate and blood pressure to detect problems early. Being in the ICU does not mean a ventilator is certain.

It is completely normal to feel confused or alarmed when you are admitted to the Intensive Care Unit (ICU) for breathing checks while your main symptom is leg weakness. In Acute Inflammatory Demyelinating Polyradiculoneuropathy (AIDP), doctors use the ICU as a proactive safety measure. AIDP often causes weakness that starts in the legs and may progress to the arms, breathing muscles, or swallowing muscles. While not everyone develops respiratory failure, monitoring you closely allows your medical team to detect early signs of muscle fatigue and support you before an emergency happens.

What This Means For You Right Now

  • Location does not equal failure: Being placed in an ICU or a high-acuity step-down unit depends on hospital protocols and your specific exam. It does not mean you will definitely need a ventilator.
  • Monitoring is separate from treatment: The ICU observation supports your breathing and heart function, which happens alongside disease-directed treatments (such as IVIG or plasma exchange) aimed at the nerve inflammation itself.
  • Oxygen monitors are not enough: A normal oxygen saturation reading on your finger does not reliably rule out early breathing muscle fatigue. This is why active, frequent breathing tests are necessary.

🚨 Symptoms to Report IMMEDIATELY

Do not wait for your next scheduled breathing test to speak up. Use your call bell to alert your nurse immediately if you experience any of the following:

  • New or worsening shortness of breath, especially when lying flat
  • Choking, coughing while drinking, or an inability to swallow your own saliva
  • A noticeable change in your voice (becoming weak, breathy, or hoarse)
  • A weaker cough
  • Unusual sleepiness, confusion, or a feeling that you cannot take a full breath

The Path of Weakness: Why Monitoring Matters

AIDP is the most common form of Guillain-Barré Syndrome (GBS). The nerve damage typically begins in the lower body but can progress over a few days to involve the upper body [1]. In about 20% to 30% of severe GBS cases overall, this progression reaches the muscles used to breathe, cough, and swallow, eventually requiring mechanical ventilation (a breathing tube) [2] [1]. Because this progression can happen quickly, frequent monitoring ensures that if your respiratory muscles tire, your airway is protected [3].

How Your Team Measures Breathing Strength

Your team will frequently ask you to perform breathing tests through a bedside tube. Clinicians track the trend of these numbers over time rather than relying on a single result [4]. You may hear them mention the “20/30/40 rule.” These are approximate clinical screening thresholds used to measure respiratory muscle fatigue:

Measurement What It Tests Warning Threshold What It Means
20 - Vital Capacity (VC) The total volume of air you can blow out after taking a deep breath. Dropping below 20 mL/kg of your body weight. Your breathing muscles may not be generating enough force for a full breath.
30 - Maximal Inspiratory Pressure (MIP) Your inhaling strength (how hard you can suck air in). Weaker than 30 cm H₂O. (Because this is often reported as a negative pressure, a value like -20 is weaker than -30). The diaphragm is struggling to maintain adequate ventilation.
40 - Maximal Expiratory Pressure (MEP) Your exhaling and coughing strength. Weaker than 40 cm H₂O. Your chest and abdominal muscles may be too weak to produce a forceful cough.

Important limitations: These numbers are bedside heuristics, not strict rules that guarantee intubation [4]. Furthermore, an effective cough relies not just on your MEP, but also on how deeply you can inhale first and the strength of your throat muscles.

Bulbar Weakness and Other Warning Signs

Modern medical guidelines advise considering your complete clinical condition rather than relying on one measurement [5]. The team is closely watching for:

  • Bulbar weakness: This refers to weakness of the muscles used for speaking, swallowing, and protecting the airway [6]. If you have trouble managing saliva or slurred speech, it is a strong predictor that breathing muscle weakness may follow [7].
  • Rapid progression: How fast your weakness is spreading from your legs to your upper body.
  • Facial weakness: A weak smile or inability to close your eyes tightly, which can sometimes accompany broader nerve involvement [7].

Beyond Breathing: The Autonomic Nervous System

There is another critical reason for your ICU stay: monitoring your autonomic nervous system [8]. This background system controls automatic functions like your heart rate and blood pressure.

In AIDP, nerve inflammation can irritate these autonomic nerves, causing a condition called dysautonomia [9]. This can lead to sudden swings in your blood pressure, abnormally fast or slow heart rhythms, and sweating changes [10]. Continuous cardiac monitoring in the ICU catches these fluctuations instantly, keeping you safe while your nerves begin to heal.

Recovery and Next Steps

Being in the ICU can be frightening, but this intensive monitoring is designed to stay ahead of the disease. If you do require a ventilator, the duration is unpredictable. Many people recover enough to breathe on their own over weeks or months as the nerves slowly repair (remyelination), though some may require prolonged support (such as a tracheostomy), and recovery can sometimes be incomplete. The ICU team’s goal is to closely observe and protect your body during the most severe phase of AIDP so you have the best possible environment to heal.

Common questions in this guide

Does ICU monitoring mean I will need a ventilator with AIDP?
No. ICU or step-down monitoring is often a proactive safety measure, and being monitored does not mean that respiratory failure or intubation is certain. The team watches breathing-test trends, cough and swallowing strength, and how quickly weakness is changing so support can start early if needed.
Why can my oxygen level look normal if AIDP affects my breathing?
A finger oxygen reading can remain normal while the muscles needed to take a deep breath, cough, or protect the airway are becoming tired. Repeated breathing-strength tests and a clinical examination can identify this problem earlier than oxygen saturation alone.
What is the 20/30/40 rule in AIDP?
The 20/30/40 rule is an approximate bedside screen: a vital capacity below 20 mL/kg, inhaling pressure weaker than 30 cm H₂O, or exhaling pressure weaker than 40 cm H₂O can signal respiratory muscle weakness. These numbers do not automatically mean someone needs a breathing tube; clinicians also consider cough strength, swallowing, bulbar weakness, and the trend over time.
Which AIDP symptoms should I report to the ICU team right away?
Report new or worsening shortness of breath, especially when lying flat; choking or trouble swallowing; difficulty handling saliva; a weak, breathy, or hoarse voice; or a weaker cough. Unusual sleepiness, confusion, or feeling unable to take a full breath also requires immediate attention.
Why are my heart rate and blood pressure being monitored in AIDP?
AIDP can affect the nerves that automatically regulate heart rate and blood pressure, a problem called dysautonomia. This can cause sudden changes in heart rhythm or blood pressure, so continuous monitoring helps the team respond promptly.
How long might breathing support last if AIDP causes respiratory failure?
The duration varies. Many people regain independent breathing over weeks or months as the nerves heal, while some need longer support, including a tracheostomy, and recovery may be incomplete.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Acute inflammatory demyelinating polyradiculoneuropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What were my baseline breathing numbers when I arrived, and how are the trends looking today?
  2. 2.What specific findings would make you recommend placing a breathing tube (intubation)?
  3. 3.Would non-invasive supports (like a BiPAP mask) be safe for me, or does my swallowing and cough strength make that risky?
  4. 4.Are my bulbar muscles (used for swallowing, speaking, and protecting my airway) showing any signs of weakness?
  5. 5.Is my heart rate and blood pressure stable, or am I showing signs of autonomic nerve involvement?

References

References (10)
  1. 1

    Guillain-Barré Syndrome.

    Donofrio PD

    Continuum (Minneapolis, Minn.) 2017; (23(5, Peripheral Nerve and Motor Neuron Disorders)):1295-1309 doi:10.1212/CON.0000000000000513.

    PMID: 28968363
  2. 2

    Guillain-Barré syndrome.

    Willison HJ, Jacobs BC, van Doorn PA

    Lancet (London, England) 2016; (388(10045)):717-27.

    PMID: 26948435
  3. 3

    Guillain-Barré Syndrome After Elective Spinal Surgery.

    Chen EY, Stratton C, Mercer B, et al.

    The Journal of the American Academy of Orthopaedic Surgeons 2017; (25(8)):587-593 doi:10.5435/JAAOS-D-16-00572.

    PMID: 28644175
  4. 4

    Neuroprognostication: Guillain-Barré Syndrome.

    Traub R, Chaudhry V

    Seminars in neurology 2023; (43(5)):791-798 doi:10.1055/s-0043-1775750.

    PMID: 37788681
  5. 5

    Guidelines for Neuroprognostication in Adults with Guillain-Barré Syndrome.

    Busl KM, Fried H, Muehlschlegel S, et al.

    Neurocritical care 2023; (38(3)):564-583 doi:10.1007/s12028-023-01707-3.

    PMID: 36964442
  6. 6

    High mortality from Guillain-Barré syndrome in Bangladesh.

    Ishaque T, Islam MB, Ara G, et al.

    Journal of the peripheral nervous system : JPNS 2017; (22(2)):121-126 doi:10.1111/jns.12215.

    PMID: 28447405
  7. 7

    Characteristics and Outcomes of Guillain-Barré Syndrome in Children.

    Nguyen TM, Tran TT, Ly KH, Trang MTH

    Neuropediatrics 2026; (57(4)):273-279 doi:10.1055/a-2886-4749.

    PMID: 42263764
  8. 8

    Autonomic involvement in Guillain-Barré syndrome: an update.

    Zaeem Z, Siddiqi ZA, Zochodne DW

    Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2019; (29(3)):289-299 doi:10.1007/s10286-018-0542-y.

    PMID: 30019292
  9. 9

    Prognostic factors for the sequelae and severity of Guillain-Barré syndrome in children.

    Estrade S, Guiomard C, Fabry V, et al.

    Muscle & nerve 2019; (60(6)):716-723 doi:10.1002/mus.26706.

    PMID: 31531862
  10. 10

    Use of pacemaker in GBS dysautonomia.

    Abbas Z, Sardar Z

    BMJ case reports 2021; (14(10)) doi:10.1136/bcr-2021-242464.

    PMID: 34645624

This page is for informational purposes only and does not constitute medical advice. Your ICU team should interpret your breathing tests and decide when breathing support is needed; report any new breathing or swallowing changes immediately.